Top compounds associated with response to CTSD


Feature Type Standardized
Nominal ANOVA
mRNA FQI-2 CTRPv2 pan-cancer AAC -0.059 0.09
mRNA WP1130 CTRPv2 pan-cancer AAC -0.064 0.09
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.068 0.09
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.061 0.1
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC 0.069 0.1
mRNA BRD-K79669418 CTRPv2 pan-cancer AAC -0.094 0.1
mRNA OSI-027 CTRPv2 pan-cancer AAC -0.062 0.1
mRNA BRD-K29086754 CTRPv2 pan-cancer AAC 0.13 0.1
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.059 0.1
mRNA BRD9876 CTRPv2 pan-cancer AAC -0.066 0.1
Download CSV